| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 03/13/2021 | 3. Issuer Name and Ticker or Trading Symbol ACORDA THERAPEUTICS INC [ ACOR ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 4,872(1) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (right to buy) | (2) | 12/01/2024 | Common Stock | 1,667 | 212.88 | D | |
| Employee Stock Option (right to buy) | (3) | 03/04/2025 | Common Stock | 35 | 214.44 | D | |
| Employee Stock Option (right to buy) | (4) | 03/02/2026 | Common Stock | 200 | 213.18 | D | |
| Employee Stock Option (right to buy) | (5) | 03/01/2027 | Common Stock | 185 | 164.85 | D | |
| Employee Stock Option (right to buy) | (6) | 04/24/2027 | Common Stock | 642 | 96 | D | |
| Employee Stock Option (right to buy) | (7) | 02/02/2028 | Common Stock | 334 | 151.8 | D | |
| Employee Stock Option (right to buy) | (5) | 03/01/2028 | Common Stock | 284 | 146.1 | D | |
| Employee Stock Option (right to buy) | (8) | 08/01/2028 | Common Stock | 334 | 148.5 | D | |
| Employee Stock Option (right to buy) | (9) | 03/08/2029 | Common Stock | 395 | 81.06 | D | |
| Employee Stock Option (right to buy) | (10) | 11/07/2029 | Common Stock | 2,584 | 14.46 | D | |
| Employee Stock Option (right to buy) | (11) | 02/16/2030 | Common Stock | 834 | 10.74 | D | |
| Explanation of Responses: |
| 1. Includes 118 unvested restricted stock awards and 3,300 unvested restricted stock unit awards issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. 59 of the restricted stock awards vest on December 1, 2021 and 59 vest on December 1, 2022, subject to continued service. The restricted stock units each represent a contingent right to one share of the Issuer's common stock, subject to continued service, vesting in installments of 40%, 20%, and 40% at 6 months, 12 months, and 18 months, respectively, after the grant date. |
| 2. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on December 1, 2018. |
| 3. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2019. |
| 4. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2020. |
| 5. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2021. |
| 6. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested based on achievement of specified performance milestones and were fully vested on April 2, 2018. |
| 7. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on February 2, 2018, with the first quarterly installment vesting on May 2, 2018. |
| 8. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on August 1, 2018, with the first quarterly installment vesting on November 1, 2018. |
| 9. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2019, with the first quarterly installment vesting on April 1, 2019. |
| 10. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on November 7, 2019, with the first quarterly installment vesting on February 7, 2020. |
| 11. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on February 16, 2020, with the first quarterly installment vesting on May 16, 2020. |
| Remarks: |
| /s/ Robert Morales | 03/22/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
